Hemogenyx Pharmaceuticals Plc Stock Today
| HOPHF Stock | USD 0 0.00 0.00% |
Performance0 of 100
| Odds Of DistressOver 70
|
Hemogenyx Pharmaceuticals is trading at 0.0031 as of the 23rd of November 2024. This is a No Change since the beginning of the trading day. The stock's lowest day price was 0.0031. Hemogenyx Pharmaceuticals has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. Equity ratings for Hemogenyx Pharmaceuticals Plc are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 24th of October 2024 and ending today, the 23rd of November 2024. Click here to learn more.
Hemogenyx Pharmaceuticals Plc, a preclinical-stage biotechnology company, focuses on the discovery, development, and commercialization of therapies and treatments for blood diseases. The company was founded in 2012 and is headquartered in London, the United Kingdom. The company has 1.14 B outstanding shares. More on Hemogenyx Pharmaceuticals Plc
Moving against Hemogenyx Pink Sheet
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Hemogenyx Pink Sheet Highlights
| Business Concentration | Biotechnology, Healthcare (View all Sectors) |
Hemogenyx Pharmaceuticals Plc [HOPHF] is a Pink Sheet which is traded through a dealer network over-the-counter (OTC). The company currently falls under 'Micro-Cap' category with a current market capitalization of 45.68 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Hemogenyx Pharmaceuticals's market, we take the total number of its shares issued and multiply it by Hemogenyx Pharmaceuticals's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Hemogenyx Pharmaceuticals classifies itself under Healthcare sector and is part of Biotechnology industry. The entity has 1.14 B outstanding shares.
Hemogenyx Pharmaceuticals Plc has accumulated about 6.84 M in cash with (2.63 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Hemogenyx Pharmaceuticals Probability Of Bankruptcy
Ownership AllocationHemogenyx Pharmaceuticals Plc has a total of 1.14 Billion outstanding shares. Hemogenyx Pharmaceuticals retains 13.01 (percent) of its outstanding shares held by insiders and 0.0 (percent) owned by outside corporations. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Hemogenyx Ownership Details
Hemogenyx Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Hemogenyx Pharmaceuticals without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Equity Forecasting Now
Equity ForecastingUse basic forecasting models to generate price predictions and determine price momentum |
| All Next | Launch Module |
Hemogenyx Pharmaceuticals Corporate Management
| Vladislav Sandler | CEO CoFounder | Profile | |
| Alexis JD | Independent Director | Profile | |
| Koen MD | Clinical Director | Profile | |
| Andrew Wright | Financial Sec | Profile |
Other Information on Investing in Hemogenyx Pink Sheet
Hemogenyx Pharmaceuticals financial ratios help investors to determine whether Hemogenyx Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Hemogenyx with respect to the benefits of owning Hemogenyx Pharmaceuticals security.